ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)

CUSIP: 04280A100

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+5,086,306
Put/Call ratio
53%
SEC-reported price per share
$62.70
Indexed holders
437
Value change
+$294,677,552
Number of buys
264
Open additional details 1 more signal available
Number of sells
175
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
141,020,453

Security key

04280A100

Report period

Q1 2026

Indexed institutions

437

Top holders

10

Ownership snapshot

Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
2/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 5% 13 rows are not safely comparable across share classes. 13D/G row: VANGUARD CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 2
VANGUARD CAPITAL MANAGEMENT LLC 5%
STATE STREET CORP 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
5%
Reported 13D/G · 31 Mar 2026
$443,997,071
7,081,293 shares
$0 31 Mar 2026
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.6%
Reported 13D/G · 30 Jun 2025
$425,150,274
6,403,830 shares
— 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$1,415,340,659
21,318,582 shares
— 31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,015,310,304
15,293,121 shares
— 31 Dec 2025
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$705,393,750
10,625,000 shares
— 31 Dec 2025
FMR LLC
13F
Company
13F
—
denominator unverified
$432,889,919
6,520,408 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
437
Shares
120,841,602
Indexed holders
437
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 indexed holders
400
Q1 2026 indexed holders
437
Indexed holder difference
37
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .